News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported
Fumiko Ladd Chino/bumpintheroad.us
Apr 6, 2025, 12:55

Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported

Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared an article by Avital M. Miller et al on X:

“Toxicity in phase III oncology clinical trials is often incompletely reported and is frequently minimized in its interpretation.

Only 1/3 reported Grade 1 to 2 toxicities and toxicity-minimizing language was used in 46% (subjectively downplay the harm of drugs).”

Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials

Authors: Avital M. Miller et al

Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported

Adina H Passy Alexander D. Sherry Avital M Miller cancer Esther J Beck Ethan B Ludmir Fumiko Ladd Chino Gabrielle S Kupferman Joseph Abi Jaoude OncoDaily Oncology Pavlos Msaouel Ramez Kouzy Timothy A Lin
Special Coverage
Opinion
Apr 6, 2025, 12:55
Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported
Insight
Apr 6, 2025, 12:51
Carolina Reduzzi and Lorenzo Gerratana on integrating CTCs and ctDNA in metastatic breast cancer management
Blog
Apr 6, 2025, 12:48
Join the AUA-IBCG Bladder Cancer Forum on April 28, 2–5 PM
Blog
Apr 6, 2025, 12:45
Supporting the development of NCCPs leads to better outcomes for everyone - UICC
Blog
Apr 6, 2025, 12:43
Yüksel Ürün: Dr. Kumar Prabhash Presents ALPHA-LUNG Study at POLES25
Blog
Apr 6, 2025, 11:59
Ivy Riano: Tips for Finding a HemeOnc Job in the U.S. on a J1 Visa
Science
Apr 6, 2025, 11:58
Sahar Mansour: First prospective study in Egypt to evaluate AI in double reading for breast cancer screening
Blog
Apr 6, 2025, 11:52
Jeff Yang: Preventive Health Care Use Among Adults Eligible for Lung Cancer Screening in the US
Blog
Apr 6, 2025, 11:47
Rahul Banerjee: Hiring Myeloma Specialist at Fred Hutchinson Cancer Center
Blog
Apr 6, 2025, 11:34
Glad to attend the 3rd Chris Wood GU Onc meeting - Kidney Cancer
Blog
Apr 6, 2025, 11:31
Sarah Louden: Best of ASCO GI - 1st Annual Officially Licensed Program with American Society of Clinical Oncology
Blog
Apr 6, 2025, 11:29
Kristina Jankovic: Older Patients Are Underrepresented in Breast Cancer Trials